AXSM

205.40

1.14% -2.37

시간 외 거래: 205.39 -0.01 -0.00%

Axsome Therapeutics Inc (AXSM)

개요 뉴스 가격 이력 옵션 체인 Financials AXSM 왜 하락? 토론 예측

전일 마감가:

$207.77

열려 있는:

$207

하루 거래량:

293.21K

Relative Volume:

0.35

시가총액:

$10.76B

수익:

$708.24M

순이익/손실:

$-188.30M

주가수익비율:

-54.93

EPS:

-3.7392

순현금흐름:

$-70.99M

1주 성능:

-5.03%

1개월 성능:

-14.77%

6개월 성능:

+20.86%

1년 성능:

+73.32%

1일 변동 폭

$205.09

$208.09

1주일 범위

$205.09

$222.46

52주 변동 폭

$112.90

$260.19

Axsome Therapeutics Inc Stock (AXSM) Company Profile

명칭

Axsome Therapeutics Inc

부문

Healthcare (1033)

산업

Biotechnology (582)

전화

(212) 332-3241

주소

ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK

직원

925

트위터

다음 수익 날짜

2026-08-10

최신 SEC 제출 서류

AXSM's Discussions on Twitter

Compare AXSM vs VRTX, REGN, ARGX, MRNA, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AXSM Axsome Therapeutics Inc	205.40	10.90B	708.24M	-188.30M	-70.99M	-3.7392
VRTX Vertex Pharmaceuticals Inc	547.59	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	828.50	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,011.11	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.89	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.58	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-02-24	개시	Wolfe Research	Outperform
2026-01-08	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2025-10-01	개시	B. Riley Securities	Buy
2025-09-03	재개	Wells Fargo	Overweight
2025-07-03	재개	Morgan Stanley	Overweight
2025-06-03	개시	Oppenheimer	Outperform
2025-04-07	개시	Jefferies	Buy
2025-02-11	개시	Deutsche Bank	Buy
2024-12-31	재확인	Mizuho	Outperform
2024-09-03	개시	Wells Fargo	Overweight
2024-08-06	업그레이드	BofA Securities	Neutral → Buy
2024-07-22	개시	Needham	Buy
2024-04-29	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-03-19	개시	Robert W. Baird	Outperform
2024-02-06	개시	UBS	Buy
2024-01-25	개시	RBC Capital Mkts	Outperform
2023-12-13	개시	Citigroup	Buy
2023-08-08	업그레이드	BofA Securities	Underperform → Neutral
2023-01-05	개시	Piper Sandler	Neutral
2022-11-01	개시	Loop Capital	Buy
2022-09-07	재개	Mizuho	Buy
2021-08-10	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-06-10	개시	Berenberg	Buy
2021-01-08	개시	Jefferies	Buy
2020-12-16	개시	Mizuho	Buy
2020-09-29	개시	BofA Securities	Underperform
2020-09-10	개시	Morgan Stanley	Overweight
2020-04-28	재확인	H.C. Wainwright	Buy
2020-04-14	개시	Cowen	Outperform
2019-12-30	재확인	H.C. Wainwright	Buy
2019-12-17	재확인	H.C. Wainwright	Buy
2019-12-16	재확인	Guggenheim	Buy
2019-10-16	개시	Guggenheim	Buy
2019-09-18	개시	William Blair	Outperform
2019-05-28	개시	SunTrust	Buy
2019-05-23	재확인	H.C. Wainwright	Buy
2019-04-08	개시	SVB Leerink	Outperform
2019-03-15	재확인	H.C. Wainwright	Buy
2016-10-03	재개	Brean Capital	Buy
2015-12-15	개시	Cantor Fitzgerald	Buy
2015-12-14	개시	Ladenburg Thalmann	Buy

모두보기

Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스

Aug 21, 2026

Enterprise value to EBIT forward of Axsome Therapeutics, Inc. – MUN:19X - TradingView

Aug 21, 2026

Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - Stocktwits

Aug 21, 2026

AXSM Stock Is Rising Today After Wall Street’s Positive Stance Despite Mixed Q1 – What's Behind The Optimism? - Stocktwits

Aug 21, 2026

Aug 20, 2026

AXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - Stocktwits

Aug 20, 2026

Zacks Research Upgrades Axsome Therapeutics (NASDAQ:AXSM) to "Hold" - MarketBeat

Aug 20, 2026

Lisanti Capital Growth LLC Acquires Shares of 20,825 Axsome Therapeutics, Inc. $AXSM - MarketBeat

Aug 20, 2026

Eagle Health Investments LP Invests $15.92 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Aug 20, 2026

Aug 19, 2026

Enterprise value to EBITDA forward of Axsome Therapeutics, Inc. – SWB:19X - TradingView

Aug 19, 2026